Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaim Putterman

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
Arthritis Care & Research|October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to TreatmentAndrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis Research & Therapy|February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus NetworkPeter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
JCI Insight|September 20, 2019
PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21Alexandra V Bocharnikov, Joshua Keegan, Vanessa S Wacleche, et al.
Autoimmunity Reviews|October 18, 2017
Novelties in the field of autoimmunity - 1st Saint Petersburg congress of autoimmunity, the bridge between east and westShani Dahan, Yahel Segal, Abdulla Watad, et al.
Lupus Science & Medicine|August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE NetworkKristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
JCI Insight|January 23, 2024
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritisAndrea Fava, Jill Buyon, Laurence Magder, et al.
Nature Communications|July 22, 2021
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amineCristina C Clement, Angelo D'Alessandro, Sangeetha Thangaswamy, et al.
The Journal of Experimental Medicine|September 3, 2025
A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritisPaul J Hoover, Chirag Raparia, David J Lieb, et al.
Rheumatology (Oxford, England)|February 25, 2022
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines PartnershipPhilip M Carlucci, Jessica Li, Andrea Fava, et al.
Nature Immunology|August 15, 2019
Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritisArnon Arazi, Deepak A Rao, Celine C Berthier, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
Arthritis Care & Research|October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to TreatmentAndrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis Research & Therapy|February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus NetworkPeter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
JCI Insight|September 20, 2019
PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21Alexandra V Bocharnikov, Joshua Keegan, Vanessa S Wacleche, et al.
Autoimmunity Reviews|October 18, 2017
Novelties in the field of autoimmunity - 1st Saint Petersburg congress of autoimmunity, the bridge between east and westShani Dahan, Yahel Segal, Abdulla Watad, et al.
Lupus Science & Medicine|August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE NetworkKristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
JCI Insight|January 23, 2024
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritisAndrea Fava, Jill Buyon, Laurence Magder, et al.
Nature Communications|July 22, 2021
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amineCristina C Clement, Angelo D'Alessandro, Sangeetha Thangaswamy, et al.
The Journal of Experimental Medicine|September 3, 2025
A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritisPaul J Hoover, Chirag Raparia, David J Lieb, et al.
Rheumatology (Oxford, England)|February 25, 2022
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines PartnershipPhilip M Carlucci, Jessica Li, Andrea Fava, et al.
Nature Immunology|August 15, 2019
Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritisArnon Arazi, Deepak A Rao, Celine C Berthier, et al.
Pageof 21